Shares of Tempus AI (TEM) plunged 5.15% in pre-market trading on Wednesday. The AI healthcare solutions provider's stock declined after William Blair downgraded the company from Outperform to Market Perform, citing valuation concerns.
According to the analysts at William Blair, the downgrade was prompted by the stock's lofty valuation levels, which they believe have become stretched relative to the company's near-term growth prospects. However, the firm did not provide a specific price target for Tempus AI.
Despite the downgrade, Tempus AI maintains an average analyst rating of Overweight and a mean price target of $58.60, according to data from FactSet. The market will closely monitor the company's upcoming earnings release and guidance to assess the validity of the valuation concerns raised by William Blair.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.